AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy programme, as per an 18 November press release. It is the first asset licensed by the British big ...

It highlights the strong commitment and rapid integration of our respective research teams as well as providing important early validation of our novel CAR-Treg cell therapy approach to autoimmune ...

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which could be worth up to $2 ...

Nonetheless, low Foxp3 differentiated Tregs into Th2 or Th17 effector cells 12, or IL-10–secreting cells resembling adaptive Tregs 1, demonstrating that Foxp3-mediated Treg induction, rather ...

T cells are central to the body's defense ... anti-tumor immunity is an emerging area in cancer therapy, systemically inhibiting Tregs can cause severe autoimmune reactions. This challenge has ...

A University professor has found a new way to treat cancer using different cell compounds, like the NR0B2 protein.

Regenerative medicine has the potential to reshape how we treat diseases, offering new hope for patients requiring cell, ...

While the human body’s immune system is generally able to defend against harmful germs, diseases like cancer are trickier to ...